Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A look back at some of the major news stories we covered this year.
Long-term remission seen in children with leukemia and adults with lymphoma.
Customized cell therapy plus Imbruvica leads to high response rate.
We asked the experts what they think will be the next big breakthroughs.
Half of those treated with the experimental immunotherapy bb2121 no longer had detectable cancer.
The new therapies include immune checkpoint inhibitors; therapeutic vaccines; CAR T-cell therapies; and “conjugate” drugs.
Rosenberg, June and Allison win award for breakthroughs in cancer immunotherapy.
The approved therapies have roiled the insurance approval process, which has led to delays and denials of coverage.
Tiny liposome-based drug carriers make tumors more vulnerable to targeted immunotherapy.
Future clinical trials will explore whether cellular and antibody-based therapies can be beneficial as earlier-stage treatments.
Study finds engineered that natural killer cells are equally effective with less toxicity.
New immunotherapy approach could make engineering immune cells faster and cheaper.
Kelly Lamphere’s multiple myeloma—which had been stabilized by chemotherapy and a stem cell transplant—had begun outsmarting her treatme...
Find out how much you know about this new approach to cancer treatment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.